Player FM - Internet Radio Done Right
Checked 25d ago
تمت الإضافة منذ قبل four أعوام
المحتوى المقدم من The Lancet and The Lancet HIV. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة The Lancet and The Lancet HIV أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.
Player FM - تطبيق بودكاست
انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
انتقل إلى وضع عدم الاتصال باستخدام تطبيق Player FM !
المدونة الصوتية تستحق الاستماع
برعاية
O
Our Skin: A Personal Discovery Podcast


1 You Are Your Longest Relationship: Artist DaQuane Cherry on Psoriasis, Art, and Self-Care 32:12
32:12
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب32:12
DaQuane Cherry was once the kid who wore a hoodie to hide skin flare-ups in school. Now he’s an artist and advocate helping others feel seen. He reflects on his psoriasis journey, the power of small joys, and why loving yourself first isn’t a cliché—it’s essential. Plus, a deep dive into the history of La Roche-Posay’s legendary spring. See omnystudio.com/listener for privacy information.…
Listen to The Lancet HIV
وسم كل الحلقات كغير/(كـ)مشغلة
Manage series 2908329
المحتوى المقدم من The Lancet and The Lancet HIV. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة The Lancet and The Lancet HIV أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.
The Lancet HIV launched in autumn 2014, joining the growing collection of Lancet specialty journals. As an exclusively online journal, this new monthly title delivers a holistic view of the pandemic, publishing original research, comment, and correspondence that unifies clinical, epidemiological, and operational disciplines across a single vision of health for those living with HIV.
…
continue reading
81 حلقات
وسم كل الحلقات كغير/(كـ)مشغلة
Manage series 2908329
المحتوى المقدم من The Lancet and The Lancet HIV. يتم تحميل جميع محتويات البودكاست بما في ذلك الحلقات والرسومات وأوصاف البودكاست وتقديمها مباشرة بواسطة The Lancet and The Lancet HIV أو شريك منصة البودكاست الخاص بهم. إذا كنت تعتقد أن شخصًا ما يستخدم عملك المحمي بحقوق الطبع والنشر دون إذنك، فيمكنك اتباع العملية الموضحة هنا https://ar.player.fm/legal.
The Lancet HIV launched in autumn 2014, joining the growing collection of Lancet specialty journals. As an exclusively online journal, this new monthly title delivers a holistic view of the pandemic, publishing original research, comment, and correspondence that unifies clinical, epidemiological, and operational disciplines across a single vision of health for those living with HIV.
…
continue reading
81 حلقات
كل الحلقات
×L
Listen to The Lancet HIV

In HIV prevention and treatment, broadly neutralising antibodies have so far failed failed to deliver on their potential; could N6LS buck the trend? Richard Wu talks about a phase 1 study with some promising results.
L
Listen to The Lancet HIV

1 In conversation with... Grace Lui and Vincent Wong 13:50
13:50
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب13:50
Join Adrian Gonzalez in conversation with Grace Lui and Vincent Wong (The Chinese University of Hong Kong) as they discuss whether a dietary and exercise programme can reduce liver fat and induce resolution of MASLD in people with HIV.
L
Listen to The Lancet HIV

1 In conversation with... Debra ten Brink and Rowan Martin-Hughes 24:00
24:00
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب24:00
Peter Hayward is joined by Debra ten Brink and Rowan Martin-Hughes of the Burnet Institute (Melbourne, Australia) as they discuss their modelling study forecasting the effects of funding cuts on HIV acquisitions and mortality.
L
Listen to The Lancet HIV

Sari Reisner (University of Michigan School of Public Health, Boston, USA) on gender-affirming hormone therapy for transgender, non-binary, and gender-diverse people in the US and its effects on HIV acquisition risk and viral suppression.
L
Listen to The Lancet HIV

1 In conversation with... Lisa Noguchi and by Nyaradzo Mgodi 23:02
23:02
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب23:02
Lisa Noghuchi of Jhpeigo (Johns Hopkins University) and Nyaradzo Mgodi (University of Zimbabwe) join Peter Hayward to discuss the MTN-043 study assessing safety and drug exposure of the dapivirine ring in breastfeeding women.
L
Listen to The Lancet HIV

Sharon Lewin (Peter Doherty Institute for Infection and Immunity, Melbourne, Australia) joins Deputy Editor, Adrian Gonzalez to talk about the requirements and challenges to develop a product for HIV cure based on cell and gene therapies.
L
Listen to The Lancet HIV

1 In conversation with... Claudia Cortés y Giovanni Ravasi (in Spanish) 33:29
33:29
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب33:29
Adrian Gonzalez entrevista a Claudia Cortes (Universidad de Chile, Santiago de Chile) y Giovanni Ravasi (Equipo de América Latina y Caribe del Fondo Mundial, Ginebra, Suiza) sobre los desafios a los que se enfrentan las poblaciones migrantes en el marco de la prevención y el tratamiento del VIH.
L
Listen to The Lancet HIV

1 In conversation with... Florence Riako Anam and Bruce Richman 25:11
25:11
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب25:11
Florence Riako Anam (Global Network of People Living with HIV, Kisumu, Kenya) and Bruce Richman (Prevention Access Campaign in New York, USA) join Adrian Gonzalez to discuss the importance of a clear message on U=U to end AIDS as a public health threat.
L
Listen to The Lancet HIV

1 In conversation with... Peter Hayward, Adrian Gonzalez, and Richard Henderson 22:39
22:39
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب22:39
Editor-in-Chief Peter Hayward is joined by Adrian Gonzalez (Deputy Editor) and Richard Henderson (Senior Editor) to reflect on 10 years since the launch of The Lancet HIV.
L
Listen to The Lancet HIV

1 In conversation with... Salome Kuchukidze and Souleymane Diabaté 23:15
23:15
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب23:15
Salome Kuchukidze (McGill University, Canada) and Souleymane Diabaté (Université Laval) join Editor-in-Chief, Peter Hayward, to talk about links between intimate partner violence and vertical HIV transmission.
L
Listen to The Lancet HIV

1 In conversation with... Jose M. Zuniga 21:43
21:43
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب21:43
Adrian Gonzalez is joined by Jose M. Zuniga (IAPAC, Fast-Track Cities Institute and UNAIDS Task Force on Urban Health) to talk about the IAPAC – Lancet HIV Commission on the future of urban HIV responses.
L
Listen to The Lancet HIV

1 Alejandro García sobre los tiempos de transición en la atención médica continuada del VIH (in Spanish) 24:37
24:37
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب24:37
Adrian Gonzalez (Editor) entrevista Alejandro García García (Departamento de Enfermedades Infecciosas del Hospital Universitario Ramon y Cajal, Instituto Ramon y Cajal de investigación Sanitaria en Madrid,España) sobre los avances en los tiempos de transición de las personas con VIH en España entre las distintas etapas de su vinculación a la atención médica, desde su diagnóstico hasta alcanzar la supresión viral.…
L
Listen to The Lancet HIV

Professor Serge Eholie (PACCI Programme, Abidjan, Côte d’Ivoire) joins Peter Hayward to discuss a recent randomised trial of treatments for HIV-2 in Burkina Faso, Côte d’Ivoire, Senegal, and Togo.
L
Listen to The Lancet HIV

1 In conversation with... Drew Voetsch and Robert Selato 21:09
21:09
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب21:09
Deputy Editor Adrian Gonzalez interviews Drew Voetsch (Division of Global HIV and TB, US Centers for Disease Control and Prevention, USA) and Robert Selato (National AIDS and Health Promotion Agency, Gaborone, Botswana) on Botswana´s accomplishments and progress towards achieving the UNAIDS 95 targets.…
L
Listen to The Lancet HIV

Editor-in-Chief Peter Hayward is joined by Adam Trickey (University of Bristol, UK) to discuss a recent study looking at trends in causes of death among people with HIV in Europe and North America.
L
Listen to The Lancet HIV

1 In conversation with... Manik Kohli, Iain Reeves, and Laura Waters 40:47
40:47
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب40:47
Deputy Editor Adrian Gonzalez interviews Manik Kohli (Institute of Global Health at the University College London, UK), Iain Reeves (Homerton Healthcare NHS Trust, UK), and Laura Waters (Central and North West London NHS Trust, UK) on how homophobia results in limitations to accessing effective interventions such as HIV PrEP, mpox vaccination and DoxyPEP.…
L
Listen to The Lancet HIV

1 In conversation with... Lulu Nair, Connie Celum, and Kenneth Ngure 14:04
14:04
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب14:04
Deputy Editor Adrian Gonzalez interviews Lulu Nair (Stellenbosch University, South Africa), Connie Celum (University of Washington, USA), and Kenneth Ngure (Jomo Kenyatta University, Kenya) to discuss HIV prevention adherence and choice of the dapivirine vaginal ring and daily oral PrEP in adolescent girls and young women in Africa.…
L
Listen to The Lancet HIV

Peter Hayward is joined by Sophia Rein of the Harvard T H Chan School of Public Health to discuss an emulation of target trials using cohort data to look at risk of cardiovascular events in people taking INSTIs for HIV.
L
Listen to The Lancet HIV

1 In conversation with... Lawrence Mbuagbaw 8:20
8:20
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب8:20
Deputy Editor Adrian Gonzalez interviews Lawrence Mbuagbaw (McMaster University, Ontario, Canada) about the CEDRIC-HIV checklist and its value in enhancing transparency, interpretation, comparability, and replicability of HIV drug resistance studies.
L
Listen to The Lancet HIV

1 In conversation with... Andreas Jahn and Nellie Wadonda-Kabondo 23:10
23:10
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب23:10
We talk to Andreas Jahn (Malawi Ministry of Health) and Nellie Wadonda-Kabondo (US CDC, Lilongwe, Malawi) about trends in HIV prevalence and incidence derived from two successive PHIA studies, and Malawi's progress towards achieving 95-95-95 goal.
L
Listen to The Lancet HIV

1 In conversation with... Eryn Braley and Mckenzie Braley 20:16
20:16
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب20:16
Deputy Editor Adrian Gonzalez interviews Eryn Braley (Cree/settler, Saddle Lake Cree Nation, University of British Columbia) and Mckenzie Braley (Cree/settler, Saddle Lake Cree Nation, Simon Fraser University) to discuss about the unique perspective that Indigenous Peoples have on the HIV epidemic, and the interactions between Indigenous identities and HIV.…
L
Listen to The Lancet HIV

1 In conversation with... Ricardo Luque and Miguel Barriga (en Español) 44:04
44:04
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب44:04
Adrian Gonzalez (Deputy Editor) entrevista a Ricardo Luque (Oficina de Salud y Derechos Sexuales y Reproductivos del Ministerio de Salud y Protección Social, Colombia) y Miguel Barriga (Organización de base comunitaria "Red Somos", Colombia) sobre la situación sanitaria de los migrantes Venezolanos con VIH en Colombia.…
L
Listen to The Lancet HIV

1 In conversation with... Denton Callander 17:55
17:55
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب17:55
Peter Hayward is joined by Denton Callander (Sexual Health Programme, Kirby Institute, New South Wales, Australia) to discuss the effects of treatment as prevention on HIV epidemiology among men who have sex with men in Australia.
L
Listen to The Lancet HIV

1 In conversation with... Andrea Wirtz and Sari Reisner 25:02
25:02
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب25:02
Editor-in-Chief Peter Hayward is joined by Andrea Wirtz (Johns Hopkins School of Public Health) and Sari Reisner (Harvard School of Public Health) to discuss their research in HIV incidence and mortality among transgender women in the eastern and southern USA.
L
Listen to The Lancet HIV

1 In conversation with... Yasmin Mohamed 16:21
16:21
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب16:21
Peter Hayward speaks to Yasmin Mohamed (Burnet Institute, Melbourne, Australia) about a trial of point-of-care early infant diagnosis of HIV in Myanmar and Papua New Guinea.
L
Listen to The Lancet HIV

1 In conversation with... Salome Kuchukhidze and Francisco Mbofana 21:43
21:43
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب21:43
Peter Hayward is joined by Salome Kuchukhidze (McGill University Department of Epidemiology, Biostatistics, and Occupational Health, Montreal, Canada) and Francisco Mbofana (National AIDS Council, Maputo, Mozambique) to talk about the effects of intimate partner violence on women's risk of HIV acquisition and engagement in the HIV treatment and care cascade.…
L
Listen to The Lancet HIV

1 In conversation with... Lise Jamieson and Gesine Mayer-Rath 25:00
25:00
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب25:00
Deputy Editor Philippa Harris talks to Lise Jamieson (Health Economics and Epidemiology Research Office, University of Witswatersrand, South Africa) and Gesine Mayer-Rath (Health Economics and Epidemiology Research Office and the University of Boston, USA) about cost-effectiveness of long-acting cabotegravir for PrEP in South Africa.…
L
Listen to The Lancet HIV

1 In conversation with... Helen Ayles and Musonda Simwinge 28:29
28:29
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب28:29
Helen Ayles (London School of Hygiene and Tropical Medicine) and Musonda Simwinga (Zambart) join Peter Hayward to discuss PopART trial (HPTN 071) papers published in the November issue of The Lancet HIV .
L
Listen to The Lancet HIV

1 In conversation with... Carol Strong and Stephane Ku 16:41
16:41
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب16:41
Carol Strong (National Cheng Kung University, Taiwan) and Stephane Ku (Taipei City Hospital, Taiwan) join Deputy Editor Philippa Harris to talk about HIV and chemsex.
L
Listen to The Lancet HIV

1 In conversation with... Elijah Kakande and Gabriel Chamie 20:17
20:17
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب20:17
Peter Hayward talks to Elijah Kakande (Infectious Diseases Research Collaboration, Uganda) and Gabriel Chamie (University of California at San Francisco, USA) about an intervention to increase tuberculosis prevention uptake among people with HIV in Uganda.
L
Listen to The Lancet HIV

Philippa Harris talks to Amir Mohareb (Massachusetts General Hospital, USA) about PrEP for people living with chronic hepatitis B.
L
Listen to The Lancet HIV

Dr Kenneth Ngure (Jomo Kenyatta University, Kenya) joins Peter Hayward to discuss PrEP roll-out in Kenya and research assessing 6 monthly dispensing of the preventive medicine with HIV self-testing.
L
Listen to The Lancet HIV

1 In conversation with... Marta Vasylyev and Casper Rokx 21:14
21:14
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب21:14
Marta Vasylyev (Astar Medical Center, Ukraine) and Casper Rokx (Erasmus University Medical Centre, Netherlands) talk to Philippa Harris about a unified European support framework to sustain the HIV care cascade in the displaced populations of war-struck Ukraine.
L
Listen to The Lancet HIV

1 In conversation with... Angela Colbers and Hylke Waalewijn 19:47
19:47
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب19:47
Dr Angela Colbers and Hylke Waalewijn (Radboud University Nijmegen Medical Center, Netherlands) join Peter Hayward to talk about developments in treatment for children with HIV.
L
Listen to The Lancet HIV

1 In conversation with... Nabila El-Bassel 14:02
14:02
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب14:02
Philippa Harris talks to Nabila El-Bassel (Columbia University, USA) about intimate partner violence and HIV.
L
Listen to The Lancet HIV

Dr Amy Justice (Yale University, USA) talks to Philippa Harris about the joint The Lancet HIV and The Lancet Healthy Longevity Series Ageing with HIV.
L
Listen to The Lancet HIV

1 In conversation with... Bridget Mugisa 13:49
13:49
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب13:49
Peter Hayward talks to Dr Bridget Mugisa (WHO, Eastern Mediterranean Office, Egypt) about a study summarising the epidemiology of HIV in the Middle East and north Africa.
L
Listen to The Lancet HIV

1 In conversation with... Aaloke Mody and Izukanji Sikazwe 20:59
20:59
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب20:59
Philippa Harris talks to Dr Aaloke Mody (Washington University School of Medicine, USA) and Izukanji Sikazwe (CIDRZ, Zambia) about their study on universal HIV treatment in Zambia.
L
Listen to The Lancet HIV

1 In conversation with... José Miro and Juliana Reyes 26:42
26:42
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب26:42
Prof José Miro (University of Barcelona) and Dr Juliana Reyes (Public Health Agency of Catalonia) speak to Editor-in-Chief Peter Hayward about SARS-CoV-2 and COVID-19 in people living with HIV.
L
Listen to The Lancet HIV

Prof Jon Shuter (Albert Einstein College of Medicine, USA) talks to Dr Philippa Harris about harm reduction for smokers with HIV.
L
Listen to The Lancet HIV

1 In conversation with... Elizabeth Marie King 13:34
13:34
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب13:34
Peter Hayward talks to Dr Elizabeth Marie King (University of British Columbia, Canada) about a Viewpoint on menopausal hormone therapy for women living with HIV.
L
Listen to The Lancet HIV

John Frater (University of Oxford) talks to Deputy Editor Philippa Harris about COVID-19 and SARS-CoV-2 vaccination in people with HIV.
L
Listen to The Lancet HIV

Dr Elias Dah (Institut National de Santé Publique, Centre Muraz, Bobo Dioulasso, Burkina Faso) joins Peter Hayward to discuss a PrEP implementation project in four countries in west Africa.
L
Listen to The Lancet HIV

Fatima Mir (Aga Khan University, Pakistan) talks to Philippa Harris about the 2019 HIV outbreak in the Larkana District of Pakistan.
L
Listen to The Lancet HIV

1 In Conversation With…Jessica Castilho and Claudia Cortes 12:11
12:11
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب12:11
Dr Jessica Castilho (Vanderbilt University Medical Centre) and Dr Claudia Cortes (University of Chile School of Medicine) join Peter Hayward to discuss their research on life expectancy for people living with HIV in Latin America and the Caribbean.
L
Listen to The Lancet HIV

Professor Chloe Orkin (Queen Mary University London, UK) joins Peter Hayward to talk about long-acting cabotegravir for HIV treatment and the 96 weeks of the FLAIR study.
L
Listen to The Lancet HIV

1 In Conversation With... Sarah Calabrese 16:16
16:16
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب16:16
Sarah Calabrese (George Washington University, USA) talks to Deputy Editor Philippa Harris about prioritising sexual pleasure and correcting misinformation in the era of U=U.
Le Minh Giang (Hanoi Medical University, Vietnam) and Todd Korthuis (Oregon Health and Science University, USA) discuss their work in Vietnam on treating opioid use disorder in people with HIV with Deputy Editor Philippa Harris.
L
Listen to The Lancet HIV

1 In Conversation With…Michael Herce, Tonia Poteat, Ward van Bilsen and Hanne Zimmerman, and Jade Pagkas-Bather 52:30
52:30
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب52:30
In a bumper edition, we talk to contributors to several papers in the December issue on diverse topics that include test-and-treat in correctional facilities, PrEP engagement in transgender women, the burden of living with HIV in MSM, and gentrification in San Francisco.
L
Listen to The Lancet HIV

Deputy Editor Philippa Harris discusses HIV testing and the HOSENG trial with researchers Mathebe Kopo (SolidarMed, Lesotho) and Alain Amstutz (Swiss Tropical and Public Health Institute, Basel, Switzerland).
L
Listen to The Lancet HIV

Susannah Mayhew (London School of Hygiene and Tropical Medicine) joins Deputy Editor Philippa Harris to discuss integration of sexual and reproductive health and HIV services.
L
Listen to The Lancet HIV

1 In Conversation With…Ankur Gupta-Wright and Melanie Alufandika-Moyo 14:11
14:11
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب14:11
Editor-in-Chief, Peter Hayward, talks to researchers from London School of Hygiene and Tropical Medicine and Melanie Alufandika-Moyo Malawi-Liverpool Wellcome Trust about their research on virological failure and HIV drug resistance in patients with HIV in hospital in Malawi.
L
Listen to The Lancet HIV

1 In Conversation With... Di Gibb and Anna Turkova 20:47
20:47
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب20:47
Researchers from the Medical Research Council Clinical Trials Unit at University College London join Editor-in-Chief Peter Hayward to discuss paediatric HIV treatment and the pharmacokinetic substudy of the ODYSSEY trial of dolutegravir for children with HIV.
L
Listen to The Lancet HIV

1 The Lancet HIV In Conversation With... Chi-Chi Udeagu 23:58
23:58
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب23:58
Deputy Editor Philippa Harris talks to Chi-Chi Udeagu (New York City Department of Health and Mental Hygiene, USA) about HIV partner services in New York City and the impact of COVID-19.
L
Listen to The Lancet HIV

1 In Conversation With... Kelly Dooley and Gavin Churchyard 14:26
14:26
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب14:26
Kelly Dooley (Johns Hopkins University, USA) and Gavin Churchyard (Aurum Institute, South Africa) discuss their trial on tuberculosis prevention in people with HIV taking dolutegravir-based antiretroviral therapy with Deputy Editor Philippa Harris.
L
Listen to The Lancet HIV

1 In Conversation With... The London Patient 36:10
36:10
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب36:10
Adam Castillejo joins The Lancet HIV ’s Editor, Peter Hayward, to talk about his experience of HIV, cancer, and becoming the second person to be cured of HIV.
L
Listen to The Lancet HIV

Deputy Editor Philippa Harris discusses viral load testing with Paul Drain (University of Washington, USA) and a trial of point-of-care testing with task shifting to improve treatment outcomes.
L
Listen to The Lancet HIV

1 HIV transmission dynamics in Rakai, Uganda 26:00
26:00
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب26:00
Joseph Kagaayi (Rakai Health Sciences Program, Uganda) and Oliver Ratman (Imperial College London, UK) talk to Editor-in-Chief Peter Hayward about the world famous research site and the insights that deep sequencing has provided into the flow of HIV in their latest research.
L
Listen to The Lancet HIV

Marta Nunes (University of the Witwatersrand, Johannesburg, South Africa) talks to Philippa Harris about vaccination response in people living with HIV and a trial of influenza vaccine dosing in pregnant women with HIV in South Africa.
L
Listen to The Lancet HIV

For World AIDS day, The Lancet HIV Deputy Editor Philippa Harris talks to Jeff Lazarus and Nikos Dedes about the importance of good health-related quality of life and the barriers people living with HIV face in achieving this.
Giuseppe Pantaleo (Service of Immunology and Allergy, Department of Medicine, Lausanne University Hospital, Switzerland) tells Peter Hayward about a phase 1 vaccine study published in the November issue of The Lancet HIV , and gives an overview of the HIV vaccine field.
L
Listen to The Lancet HIV

Julia Marcus and Douglas Krakower talk to Peter Hayward about the use of electronic health record data to predict HIV risk and identify PrEP candidates.
L
Listen to The Lancet HIV

The Lancet HIV Editor Peter Hayward talks to Beatriz Grinsztejn (Evandro Chagas National Institute of Infectious Diseases, Fiocruz, Rio de Janeiro, Brazil) about ACTG A5288, an international, multiarm trial investigating management of second-line treatment failure
L
Listen to The Lancet HIV

1 Assessing the safety of a PrEP intravaginal ring 17:21
17:21
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب17:21
The Lancet HIV Deputy Editor Philippa Harris talks to Betsy Herold (Albert Einstein College of Medicine, USA) about her trial investigating a tenofovir disoproxil fumarate intravaginal ring for pre-exposure prophylaxis in sexually active women.
L
Listen to The Lancet HIV

1 Safer conception for couples living with HIV 24:18
24:18
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب24:18
Sheree Schwartz (Johns Hopkins School of Public Health) talks to The Lancet HIV Editor-in-Chief Peter Hayward about the Sakh'umndeni Safer Conception Project safer conception project for South African couples living with HIV.
L
Listen to The Lancet HIV

Sunil Solomon (Johns Hopkins School of Medicine, USA) discusses the trials and tribulations of investigating integrated HIV testing, prevention, and treatment centres for people who inject drugs and men who have sex with men in India.
L
Listen to The Lancet HIV

1 Tackling drug use to improve ART adherence 13:14
13:14
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب13:14
The Lancet HIV Editor Peter Hayward talks to Evgeny Krupitsky about a trial investigating the potential of slow-release naltrexone to improve HIV treatment adherence in drug users in St Petersburg.
L
Listen to The Lancet HIV

The Lancet HIV Deputy Editor Liz Zuccala joins Stephanie Cohen to discuss a case report of an individual who acquired HIV despite reporting good adherence to PrEP.
L
Listen to The Lancet HIV

For World AIDS Day we explore how, despite huge advances, children are affected by HIV in 2018. We speak to Martina Penazzato of WHO on drug options and development, to Mark Cotton (Stellenbosch University) on the course of HIV management from infancy to adolescents (12 min 03), and to Tamsen Rochat (Human Sciences Research Council in South Africa) on how HIV still impacts the lives of children who don’t have the virus (26 min 33).…
L
Listen to The Lancet HIV

Andrew Grulich joins The Lancet HIV editor-in-chief Peter Hayward to discuss the EPIC-NSW study, looking at the population-level effectiveness of PrEP in New South Wales, Australia.
L
Listen to The Lancet HIV

Peter Hayward and Gregg Gonsalves discuss a new modelling study looking at an outbreak of HIV in Scott County, Indiana, USA.
L
Listen to The Lancet HIV

1 Internet-based intervention for people with HIV and depressive symptoms 11:10
11:10
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب11:10
Peter Hayward, editor-in-chief of The Lancet HIV , talks to Sanne van Luenen about her recent work on a new intervention for individuals with HIV and depressive symptoms.
L
Listen to The Lancet HIV

1 Enhanced treatment and prevention in sex workers 16:31
16:31
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب16:31
Frances Mary Cowan, an author of the SAPPHI-IRe trial, talks to The Lancet HIV about efforts to improve HIV services for this key population in Zimbabwe.
Geoffrey Gottlieb and Robert Smith talk with The Lancet HIV about enhancing care and clinical management of patients infected with HIV-2.
L
Listen to The Lancet HIV

1 Potential non-disclosed MSM in UK HIV networks 10:11
10:11
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب10:11
Manon Ragonnet-Cronin joins The Lancet HIV Editor, Peter Hayward, to discuss the use of phylogenetic analysis to gain insight into HIV transmission in the UK, the potential role of non-disclosed MSM, and targeting of HIV interventions.
L
Listen to The Lancet HIV

1 Journal expansion and early treatment of infants with HIV 10:24
10:24
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب10:24
Editor-in-Chief of The Lancet HIV Peter Hayward discusses the new look journal and talks to Louise Kuhn, an author of the journal's first Review, about the opportunities and possibilities of starting antiretroviral therapy soon after birth in infants with HIV.
L
Listen to The Lancet HIV

1 Universal test and treat: The Lancet HIV: November 30, 2017 10:32
10:32
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب10:32
Francois Dabis discusses his paper on universal test and treat and the HIV epidemic in rural South Africa.
L
Listen to The Lancet HIV

1 PrEP in African women: The Lancet HIV: October 31, 2017 8:57
8:57
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب8:57
Linda-Gail Bekker discusses her trial of the feasibility of non-daily pre-exposure prophylaxis dosing on African women.
L
Listen to The Lancet HIV

1 HIV disparity modelling: The Lancet HIV: April 18, 2017 19:20
19:20
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب19:20
Steven Goodreau and Eli Rosenberg explain their modelling of the causes of disparities in HIV incidence among black and white men who have sex with men in Atlanta, GA, USA.
L
Listen to The Lancet HIV

1 HIV in transgender women in Brazil: The Lancet HIV: February 7, 2017 7:40
7:40
التشغيل لاحقا
التشغيل لاحقا
قوائم
إعجاب
احب7:40
Beatriz Grinsztejn discusses the prevalence of HIV among transgender women in Rio de Janeiro, Brazil.
L
Listen to The Lancet HIV

Audio discussion of developments in the HIV field with three leading experts.
مرحبًا بك في مشغل أف ام!
يقوم برنامج مشغل أف أم بمسح الويب للحصول على بودكاست عالية الجودة لتستمتع بها الآن. إنه أفضل تطبيق بودكاست ويعمل على أجهزة اندرويد والأيفون والويب. قم بالتسجيل لمزامنة الاشتراكات عبر الأجهزة.